MARIBEL MONTANO: Open Payments
NPI 1821500497 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 22 payments from 9 companies in 2025. Trend: 2023 $504 · 2024 $802 · 2025 $419
Food & beverage: $379Education: $40
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $73 |
| Amgen Inc. | 4 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Lilly USA, LLC | 3 | $55 |
| Paratek Pharmaceuticals, Inc. | 3 | $49 |
| Madrigal Pharmaceuticals | 1 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $27 |
| Exact Sciences Corporation | 1 | $22 |
| Medtronic, Inc. | 1 | $19 |
Products named: Kerendia, Ozempic, NUZYRA, MOUNJARO, OTEZLA, REZDIFFRA, KRYSTEXXA, FARXIGA.
Industry payments across TX — which companies pay providers there.
